Emerald Acquisition’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	$67K	Sell	21,550 -59,054	-73%	-$184K	﹤0.01%	2867
2016 Q2	$137K	Buy	+80,604	New	+$137K	﹤0.01%	2788